Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

UPDATE ON DISCLOSEABLE TRANSACTION

LOAN TRANSACTION

DISMISSAL OF NOTICE OF APPEAL

References are made to the announcements dated 10 September 2018 and 26 September 2019 respectively, the paragraph headed "Money Lending" on pages 26 to 27 of the announcement of the final results for the eighteen months ended 31 December 2019 dated 30 March 2020, the announcements dated 28 April 2020, 6 May 2020 and 19 May 2020 respectively, the paragraph headed "Money Lending" on pages 21 to 24 of the announcement of the interim results for the six months ended 30 June 2020 dated 27 August 2020, the announcements dated 29 October 2020 and 10 November 2020 and the paragraph headed "Money Lending" on pages 23 to 27 of the announcement of annual results for the year ended 31 December 2020 dated 30 March 2021 of China Medical & HealthCare Group Limited (the "Company"). Capitalised terms used herein shall have the same meanings as those defined in the aforesaid announcements unless the context requires otherwise.

As disclosed in the announcement of the Company dated 29 October 2020, the High Court of Hong Kong (the "Court") made an Order on 23 October 2020 (the "Order") in favour of the Lender (a wholly-owned subsidiary of the Company) and it was ordered that, among other things, the Amended Statement of Claim be struck out on the basis that the Plaintiff has no locus standi to bring or continue the proceedings against the Lender. For details of the proceedings against the Lender, please refer to the announcement of the Company dated 19 May 2020.

As disclosed in the announcement of the Company dated 10 November 2020, the Plaintiff filed a Notice of Appeal (the "Appeal") with the Court to appeal against the Order.

At a hearing held in the Court on 8 April 2021, the Appeal was dismissed by the Court with costs payable by the Plaintiff to the Lender forthwith to be summarily assessed.

- 1 -

By Order of the board of Directors

China Medical & HealthCare Group Limited

Chong Sok Un

Deputy Chairman

Hong Kong, 20 April 2021

As at the date of this announcement, the board of Directors comprises:

Executive Directors

Ms. Chong Sok Un (Deputy Chairman), Mr. Kong Muk Yin, Mr. Guo Meibao and Mr. Zhou Haiying

Non-Executive Directors

Dato' Wong Peng Chong, Mr. Zheng Zhen and Mr. Lai Hin Wing Henry Stephen Independent Non-Executive Directors

Mr. Zhang Jian, Dr. Xia Xiaoning, Dr. Wong Wing Kuen, Albert and Ms. Yang Lai Sum, Lisa

- 2 -

Attachments

  • Original document
  • Permalink

Disclaimer

China Medical & HealthCare Group Ltd. published this content on 20 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2021 08:51:00 UTC.